Detalhe da pesquisa
1.
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Hematol Oncol
; 39(3): 293-303, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33742718
2.
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma.
Ann Hematol
; 100(2): 437-443, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33392702
3.
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis.
Cancer
; 125(5): 750-760, 2019 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30561775
4.
Regulation of B-cell-activating factor expression on the basophil membrane of allergic patients.
Int Arch Allergy Immunol
; 166(3): 208-12, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25924578
5.
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma.
medRxiv
; 2023 Dec 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38106151
6.
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing.
EClinicalMedicine
; 60: 102016, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37396800
7.
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis.
Oncotarget
; 8(4): 5924-5935, 2017 Jan 24.
Artigo
Inglês
| MEDLINE | ID: mdl-27779105
8.
Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.
Cytometry B Clin Cytom
; 90(1): 81-90, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26287276
9.
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.
Oncoimmunology
; 4(11): e1047580, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26451323
10.
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.
J Mol Diagn
; 17(6): 652-60, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26319783